Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$0.58 - $1.09 $17 - $32
-30 Closed
0 $0
Q1 2021

Apr 28, 2021

BUY
$1.62 - $3.05 $48 - $91
30 New
30 $0
Q4 2020

Feb 09, 2021

SELL
$1.44 - $1.98 $43 - $59
-30 Closed
0 $0
Q2 2020

Aug 11, 2020

SELL
$0.75 - $1.29 $450 - $774
-600 Reduced 95.24%
30 $0
Q1 2020

May 15, 2020

BUY
$0.33 - $1.62 $207 - $1,020
630 New
630 $1,000
Q3 2019

Oct 17, 2019

SELL
$1.25 - $5.0 $926 - $3,705
-741 Closed
0 $0
Q2 2019

Aug 05, 2019

BUY
$1.65 - $6.72 $765 - $3,118
464 Added 167.51%
741 $1,000
Q1 2019

Apr 16, 2019

BUY
$4.84 - $9.07 $242 - $453
50 Added 22.03%
277 $2,000
Q4 2018

Jan 17, 2019

BUY
$4.21 - $14.28 $955 - $3,241
227 New
227 $1,000

Others Institutions Holding ECOR

About electroCore, Inc.


  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $455M
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.